Featured Research

from universities, journals, and other organizations

Nicotine Patch Helps Control Symptoms Of Tourette's Syndrome In Children And Adolescents

Date:
September 18, 2001
Source:
University Of South Florida Health Sciences Center
Summary:
A nicotine patch boosts the effectiveness of drugs administered to relieve the involuntary movements and other symptoms of Tourette's syndrome — even when the drug dosage is cut in half, a University of South Florida College of Medicine study found.

TAMPA, Fla (Sept. 17, 2001) — A nicotine patch boosts the effectiveness of drugs administered to relieve the involuntary movements and other symptoms of Tourette's syndrome — even when the drug dosage is cut in half, a University of South Florida College of Medicine study found.

The double-blind, placebo-controlled study, published in the September issue of the Journal of Clinical Psychiatry, was funded by the National Institute of Neurological Disorders and Stroke and the Tourette's Syndrome Association of America. It demonstrated that a low-dose nicotine patch may be useful, particulary in alleviating the motor tics of children with Tourette's syndrome.

"Not only was the nicotine patch effective, but a much smaller dose of the medication haloperidol could be given," said first author Archie Silver, MD, USF professor of psychiatry. "That's especially important when treating children and adolescents."

Physicians typically treat Tourette's with haloperidol (Haldol) or drugs of a similar class, powerful tranquilizers that helps control symptoms but often may also severely slow down motor function and dull the ability to think.

The USF study builds on a growing body of research showing that the chemical nicotine, separated from its addictive effect in tobacco, may have therapeutic benefits for those with neuropsychiatric disorders.

The researchers followed 70 patients with Tourette's syndrome, ages 8 to 18, who received Haldol and a daily 7-mg nicotine patch, similar to the over-the-counter ones used by smokers trying to quit. Nicotine in the patch is absorbed through the skin and reaches its maximum level in the blood in about three hours — much more slowly than by smoking a cigarette.

Half the children and adolescents received real patches and the other half were given inactive, or control, patches.

The study found that the severity and frequency of motor tics were substantially relieved for those with the active nicotine patches. They did better than the control group, both when receiving the optimal dose of Haldol and when the Haldol dose was reduced by 50 percent. Even when their patches were removed for two weeks, patients who had been exposed to nicotine continued to have superior symptom control with lower than usual doses of Haldol.

There was no evidence of nicotine dependence, but those with the nicotine patch experienced more side effects, primarily nausea and dizziness. Nicotine-related side effects may limit widespread use of the patch for supplemental treatment of Tourette's, the researchers conclude, but an occasional patch may be worth trying for patients who cannot control their symptoms with standard drugs.

The researchers are unsure how nicotine works to control sudden involuntary movements, but they suspect that the chemical may turn off a specific nicotine receptor involved in the brain chemistry of people with Tourette's.

"This study is important because it focuses attention on a nicotine receptor system in the brain that has been underemphasized in neurodevelopmental disorders of childhood until now," Dr. Silver said.

The real interest in nicotine as a potential therapy is shifting to the search for artifical compounds that would mimic the effects of the drug without its addictive risks or unwanted side effects.

"Now that we understand more about how nicotine works in the brain, we're looking for nicotine substitutes that could more precisely target specific brain disorders and have fewer side effects than the patches," said principal investigator Paul R. Sanberg, PhD, DSc, professor of neurosurgery and director of the Neuroscience Program at USF.

For example, Dr. Sanberg said, another USF double-blind study reported this month in the Journal of the American Academy of Child and Adolescent Psychiatry, found that the drug mecamylamine (Inversine) appeared to be safe for children and to help those who experience mood disorders such as depression, aggression or anxiety along with Tourette's syndrome. Further research is needed to determine if mecamylamine can also boost Haldol's effectiveness in reducing motor tics in the same way that nicotine does. The mecamylamine study was funded by Layton Bioscience Inc.


Story Source:

The above story is based on materials provided by University Of South Florida Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of South Florida Health Sciences Center. "Nicotine Patch Helps Control Symptoms Of Tourette's Syndrome In Children And Adolescents." ScienceDaily. ScienceDaily, 18 September 2001. <www.sciencedaily.com/releases/2001/09/010918134808.htm>.
University Of South Florida Health Sciences Center. (2001, September 18). Nicotine Patch Helps Control Symptoms Of Tourette's Syndrome In Children And Adolescents. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2001/09/010918134808.htm
University Of South Florida Health Sciences Center. "Nicotine Patch Helps Control Symptoms Of Tourette's Syndrome In Children And Adolescents." ScienceDaily. www.sciencedaily.com/releases/2001/09/010918134808.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins